Inside CVS Caremark’s move that broke Humira’s hold on the market
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) For the first time in April, biosimilars
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) For the first time in April, biosimilars
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Transcarent’s $126 million Series D round, which
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) A Y Combinator-backed startup just raised fresh
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) The healthcare industry may never be the
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Define Ventures has hired longtime Evolent Health
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Medtronic is getting ready for a world
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Morgan Health, the health venture JP Morgan
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Color Health is betting its future on
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Americans are on the hook for more
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Digital health company Hims & Hers has